Iindaba

I-New Delhi, JUNI 22 (XINHUA) - i-chinhua ye-charri i-biop biovaxin ye-Biotech iboniswe nge-77.8 yeepesenti zokusebenza kakuhle kwiimvavanyo zeSigaba III, iindaba zendawo ezininzi zixelwe ngoLwesibini.

"I-Bhat Bio bibi biovin yi-77.8 pesenti isebenza ekukhuseleni ngokuchasene neCovid-19, ngokwedatha evela kwi-25,800 yabathathi-nxaxheba kwi-India," watsho ingxelo.

Ixabiso le-eleccocy laphuma ngoLwesibini emva kokuba iKomiti yeZiyobisi IKomiti yesiFundo ye-India (i-DCGI) ye-DCGI)

Inkampani yamayeza yayingenise idatha yenqanaba le-III ye-III yeSigaba se-III ye-DCGI kwi-DCGI ngempelaveki.

Iingxelo zithi inkampani kulindeleke ukuba ibambe intlanganiso "yokungenisa" i-World World Gosts ngoLwesithathu, ukuxoxa ngezikhokelo zokungeniswa kokugqibela kwedatha efunekayo kunye namaxwebhu.

I-Indiya yaqala ukugonya kakhulu ngokuchasene neCovid-19 ngoJan.

I-Serum Iziko le-Indiya (i-SII) livelisa i-covinish ye-Astrazeneca-Oxforfon, ngelixa iBharat bioch idibene neBhunga laseIndiya loPhando lwezoNyango (i-ICMR) kwimveliso ye-Covaxin.

I-sputminik ye-Sputnik eyenziwe nge-sputnik eyenziwe nge-sputnik yaqengqeleka yelizwe. Isiphelo